rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Samrat Pharmachem Ltd. - Research Center
530125 SAMRATPH Group (X) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income
Operating income 310.65 221.81 179.02 137.45 111.14
Expenses
Material consumed 277.87 189.90 164.25 125.62 102.62
Manufacturing expenses 4.01 3.77 2.86 2.24 2.19
Personnel expenses 1.88 1.77 1.50 1.44 1.38
Selling expenses 0.01 0.02 0.04 0.02 0.01
Adminstrative expenses 2.96 2.00 1.70 1.51 1.75
Expenses capitalised - - - - -
Cost of sales 286.72 197.47 170.35 130.82 107.96
Operating profit 23.93 24.34 8.67 6.63 3.18
Other recurring income 0.48 0.55 0.46 0.57 0.46
Adjusted PBDIT 24.41 24.89 9.13 7.20 3.63
Financial expenses 1.23 0.67 1.28 0.98 1.06
Depreciation 0.64 0.59 0.49 0.43 0.42
Other write offs - - - - -
Adjusted PBT 22.53 23.62 7.36 5.80 2.16
Tax charges 5.90 6.42 2.01 1.55 0.62
Adjusted PAT 16.63 17.21 5.35 4.25 1.54
Non recurring items - -0.02 -0.02 -0.01 -
Other non cash adjustments - - - - -
Reported net profit 16.63 17.18 5.33 4.24 1.54
Earnigs before appropriation 60.36 43.73 26.55 21.21 16.98
Equity dividend 0.31 - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 60.05 43.73 26.55 21.21 16.98
Close
Add Samrat Pharmachem Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Samrat Pharmachem Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close